Intelence and Polaramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intelence (etravirine) and Polaramine (dexchlorpheniramine maleate). Common drug interactions include antithrombin iii decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Intelence and Polaramine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

What is Polaramine?

Polaramine has active ingredients of dexchlorpheniramine maleate. It is often used in allergic rhinitis. eHealthMe is studying from 10,531 Polaramine users. Check the latest studies of Polaramine.

On Jul, 16, 2026

11 people who take Intelence and Polaramine together, and have interactions are studied.

Intelence and Polaramine drug interactions.

What are the common drug interactions of Intelence and Polaramine, by gender? *:

female:

n/a

male:

Antithrombin iii decreased
Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
Haematemesis (vomiting of blood)
Headache (pain in head)
Nasal sinus cancer (cancer of hollow cavity behind nose)
Abdominal pain
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Hypertension (high blood pressure)
Intestinal obstruction

What are the common drug interactions of Intelence and Polaramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gastric ulcer (stomach ulcer)
Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
Haematemesis (vomiting of blood)
Headache (pain in head)
Abdominal pain
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Hypertension (high blood pressure)
Intestinal obstruction
Nausea (feeling of having an urge to vomit)
Antithrombin iii decreased

50-59:

n/a

60+:

Lip and/or oral cavity cancer (cancer of lip or mouth)
Nasal sinus cancer (cancer of hollow cavity behind nose)

What are the existing conditions these people have? *

Itching: 7 people, 63.64%
Hiv Infection: 7 people, 63.64%
Dyslipidaemia (abnormal amount of lipids): 5 people, 45.45%
Nasal Sinus Cancer (cancer of hollow cavity behind nose): 3 people, 27.27%
Lip And/or Oral Cavity Cancer (cancer of lip or mouth): 3 people, 27.27%
Sputum Abnormal: 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Anaemia (lack of blood): 2 people, 18.18%
Antithrombin Iii Decreased: 2 people, 18.18%
Cytomegalovirus Infection: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Intelence and Polaramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously